Here's What Key Metrics Tell Us About RXO (RXO) Q3 Earnings

06.11.25 15:30 Uhr

Werte in diesem Artikel
Aktien

10,60 EUR -3,80 EUR -26,39%

RXO (RXO) reported $1.42 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 36.6%. EPS of $0.01 for the same period compares to $0.05 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $1.45 billion, representing a surprise of -2.01%. The company delivered an EPS surprise of -66.67%, with the consensus EPS estimate being $0.03.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how RXO performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Revenue- Eliminations: $-60 million versus $-51 million estimated by four analysts on average.Revenue- Truck brokerage: $1.04 billion compared to the $1.07 billion average estimate based on four analysts.Revenue- Complementary services: $442 million versus the four-analyst average estimate of $432.42 million.Revenue- Managed transportation: $137 million versus the four-analyst average estimate of $140.3 million.Revenue- Last mile: $305 million versus the four-analyst average estimate of $292.12 million.Gross margin- Complementary services: $94 million versus $94.75 million estimated by two analysts on average.Gross margin- Truck brokerage: $140 million compared to the $148.96 million average estimate based on two analysts.View all Key Company Metrics for RXO here>>>Shares of RXO have returned -2.9% over the past month versus the Zacks S&P 500 composite's +1.3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report RXO INC (RXO): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: RXO und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf RXO

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf RXO

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Tell S.A.

Wer­bung